Methods of using expandable foam-like biomaterials
View Patent ↗Liquid, injectable, aqueous solutions are transformed in situ to an expandable foam-like, space filling, and adherent biomaterial. Preferably, the foam-like biomaterial is the reaction product of a two-part liquid system to achieve the in situ formation thereof. The liquid system is generally comprised of a protein solution and a cross linker solution which may either be premixed and then applied to a site in need of the biomaterial, or simultaneously mixed and delivered through an in-line mixing/dispensing tip directly to the site. In especially preferred embodiments, an expandable foam-like biomaterial includes the reaction product of human or animal-derived protein material and a di- or polyaldehyde in the presence of a bicarbonate and an acidic titrant amounts sufficient to impart a cellular foam structure to the material.
1. A method of treating a tissue site comprising: applying to the tissue site a proteinaceous pre-polymeric liquid material and a cross linker solution; combining the proteinaceous pre-polymeric liquid material and the cross linker solution to produce a mixture; introducing or producing a gaseous blowing agent into the proteinaceous pre-polymeric liquid material or the mixture; and allowing the mixture to solidify at the tissue site to thereby form a biopolymeric material having a cellular foam structure, to treat the tissue site.
2. The method of claim 1 , wherein the proteinaceous pre-polymeric liquid material comprises an aqueous solution of human or animal-derived protein material, and the cross-linker solution comprises an aqueous solution of a di- or polyaldehyde material.
3. The method of claim 2 , wherein the aqueous solution of human or animal-derived protein material includes a bicarbonate, and the aqueous solution of di- or polyaldehyde includes an acidic titrant.
4. The method of claim 2 or 3 , wherein the biopolymeric material has a volume which is greater than combined volumes of the aqueous solutions.
5. The method of claim 2 , wherein the aqueous solution of human or animal-derived protein material is neutral or alkaline.
6. The method of claim 2 , wherein the aqueous solution of a di- or polyaldehyde material is acidic.
7. The method of claim 2 , wherein the aqueous solutions are introduced as a mixture onto the tissue site.
8. The method of claim 1 or 2 , further comprising incorporating into the mixture a biocompatible fibrous or particulate matter.
9. The method of claim 2 , wherein the tissue site is in need of repair and wherein the method comprises applying the proteinaceous pre-polymeric liquid to the tissue site in sufficient quantity to repair the tissue site.
10. A method of treating a tissue site comprising: applying to the tissue site a two-part mixture which comprises a Part A and a Part B, wherein the Part A includes an aqueous solution of a human- or animal-derived protein material and a bicarbonate compound, and the Part B includes an aqueous solution of a di- or polyaldehyde and a titrant, and wherein the bicarbonate compound and the titrant react to produce a gas into the mixture; allowing the two-part mixture to react and solidify at the tissue site, thereby forming a biopolymeric material having a cellular foam structure, to treat the tissue site.
11. The method of claim 10 , wherein the bicarbonate compound is sodium bicarbonate, potassium bicarbonate, or ammonium bicarbonate.
12. The method of claim 10 , wherein the titrant is phosphoric acid, sulfuric acid, hydrochloric acid, citric acid, or acetic acid.
13. The method of claim 10 , wherein the human- or animal-derived protein material comprises a serum albumin.
14. The method of claim 10 , wherein the di- or polyaldehyde comprises a glutaraldehyde.
15. The method of claim 10 , wherein the biopolymeric material adheres to the tissue site.
16. The method of claim 1 , further comprising expelling the proteinaceous pre-polymeric liquid material from a first chamber and expelling the cross linker solution from a second chamber, and passing the expelled materials into a mixing tip comprising static mixing elements that cause the proteinaceous pre-polymeric liquid material and the cross linker solution to combine to form the mixture.
17. The method of claim 16 , wherein the proteinaceous pre-polymeric liquid material comprises a serum albumin.
18. The method of claim 16 , wherein the crosslinker solution comprises glutaraldehyde.
19. The method of claim 1 , wherein the biopolymeric material adheres to the tissue site.